Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

Delayed Data
As of Apr 28
 -0.2008 / -2.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +190.32% increase from the last price of 7.75.

Analyst Recommendations

There are no recommendations available.


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.35%
Growthannually -5.22%


Growthquarterly 10.43%
Growthannually --
Key to the earnings and sales forecast charts.